Author:
Merseburger A.S.,Kuczyk M.A.,Wolff J.M.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Bono JS de, Logothetis CJ, Molina A et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995–2005
2. Gelmann EP (2002) Molecular biology of the androgen receptor. J Clin Oncol 20(16):3001–3015
3. Gregory CW, He B, Johnson RT et al (2001) A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61:4315–4319
4. Harris WP, Mostaghel EA, Nelson PS (2009) Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Prac Urol 6(2):76–85
5. Heidenreich A, Bastian PJ, Bellmunt J et al (2012) Guidelines on prostate cancer. European Association of Urology, Arnheim, The Netherlands, pp 142–162
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献